Clinical Trial

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Name: Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA — clinical trial record (NCT07548671)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine monotherapy in the treatment of newly-diagnosed tansfusion-dependent non-severe aplastic anemia (TD-NSAA).

Trial Details

NCT Number	NCT07548671
Lead Sponsor	Peking Union Medical College Hospital
Conditions	Transfusion-dependent Non-severe Aplastic Anemia
Enrollment	90 participants
Start Date	2026-04
Primary Completion	2028-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-23